Table 1. Demographic and clinical characteristics of the ALS and control groups.
| ALS group | Control group | ||||
|---|---|---|---|---|---|
| % | median (IQR) | % | median (IQR) | p | |
| Sex (m/f) | 62.8/34.9 | - | 62.8/34.9 | - | .590 |
| Age | - | 62 (15) | - | 11.8 (16) | .864 |
| Education (years) | - | 12 (5) | - | 12 (5) | .804 |
| HADS | - | 7 (9) | - | 6.5 (5) | .676 |
| Disease duration (months) | - | 18 (20) | - | - | - |
| Bulbar onset, no. (%) | 23.80 | - | - | - | - |
| ALSFRS-R | - | 36.5 (12) | - | - | - |
| Cough Peak Flow | - | 295 (202.5) | - | - | - |
| Disease progression rate | - | 0.5 (0.67) | - | - | - |
IQR: interquartile range; p values from Mann-Whitney U test.